Austco Healthcare Ltd (ASX: AHC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Austco Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $98.30 million
P/E Ratio 11.79
Dividend Yield 0.00%
Shares Outstanding 364.06 million
Earnings per share 0.023
Dividend per share 0.00
Year To Date Return 35.30%
Earnings Yield 8.48%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Austco Healthcare Ltd (ASX: AHC)
    Latest News

    a woman
    ⏸️ Investing

    These 3 stocks could shoot the lights out

    Is it time to buy these outperforming small-caps? A quick look at Nanosonics Limited (ASX:NAN), Azure Healthcare Ltd (ASX:AZV), and…

    Read more »

    a woman
    ⏸️ Investing

    Why Azure Healthcare Ltd looks a great buy at current prices

    Azure Healthcare Ltd (ASX:AZV) has strong operating leverage to the fast growing health care market.

    Read more »

    ⏸️ Investing

    4 ASX stocks soaring today

    Can these four stocks deliver more gains, or this just a flash in pan?

    Read more »

    a woman
    ⏸️ Investing

    3 reasons health stocks rock and 3 stock ideas

    Over the last five years healthcare stocks have thumped the index - are you missing out on the best sector…

    Read more »

    ⏸️ Investing

    Smart money small-caps: Azure Healthcare Ltd and Money3 Corporation Limited

    Successful small-cap investing will smash the returns available from larger companies - but you have to get it right.

    Read more »

    a woman
    ⏸️ Investing

    Will these companies be Australia's next healthcare giants?

    Nurse call systems may be the next boom industry.

    Read more »

    a woman
    ⏸️ Investing

    Beat the big fund managers with these 3 rocketing microcaps

    These three stocks are up 1,200%, 270%, and 650% - and the market is only just waking up to their…

    Read more »

    ⏸️ Investing

    5 biotech stocks to add excitement to your portfolio

    3 of them are even growing profits at a strong pace

    Read more »

    a woman
    ⏸️ Investing

    3 clever companies for any healthy share portfolio

    CSL, Azure Healthcare and Anteo Diagnostics are all in the business of commercialising the inventions of clever scientists. Better yet,…

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    02 Mar 2023 $0.0018 100.00% Interim 05 Apr 2023
    16 Sep 2022 $0.0030 100.00% Final 07 Oct 2022

    AHC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Austco Healthcare Ltd

    Austco Healthcare Ltd engages in the development and provision of electronic communications and clinical management solutions. It offers Tacera, a nurse call, and healthcare communication system for healthcare professionals and patient. The group is segmented into four geographic regions consisting of Australia/New Zealand, Asia, Europe, and North America.

    AHC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 Dec 2024 $0.27 $0.00 0.00% 392,951 $0.27 $0.27 $0.27
    19 Dec 2024 $0.27 $0.00 0.00% 1,301,957 $0.27 $0.27 $0.26
    18 Dec 2024 $0.27 $0.02 8.00% 2,005,569 $0.27 $0.27 $0.26
    17 Dec 2024 $0.25 $0.00 0.00% 495,412 $0.25 $0.27 $0.25
    16 Dec 2024 $0.25 $0.01 4.08% 55,502 $0.24 $0.25 $0.24
    12 Dec 2024 $0.25 $0.00 0.00% 2,560 $0.25 $0.25 $0.25
    11 Dec 2024 $0.25 $0.00 0.00% 94,085 $0.24 $0.25 $0.24
    10 Dec 2024 $0.25 $0.00 0.00% 59,142 $0.24 $0.25 $0.24
    09 Dec 2024 $0.25 $0.00 0.00% 8,135 $0.25 $0.25 $0.25
    06 Dec 2024 $0.25 $0.00 0.00% 42,489 $0.24 $0.25 $0.24
    05 Dec 2024 $0.25 $0.00 0.00% 16,988 $0.25 $0.25 $0.24
    04 Dec 2024 $0.25 $0.00 0.00% 46,250 $0.25 $0.25 $0.24
    03 Dec 2024 $0.25 $0.00 0.00% 203,366 $0.25 $0.25 $0.25
    02 Dec 2024 $0.25 $-0.01 -4.00% 107,953 $0.24 $0.25 $0.24
    28 Nov 2024 $0.25 $0.00 0.00% 50,301 $0.24 $0.25 $0.24
    27 Nov 2024 $0.25 $0.00 0.00% 219 $0.25 $0.25 $0.25
    26 Nov 2024 $0.25 $0.00 0.00% 72,744 $0.25 $0.25 $0.24
    25 Nov 2024 $0.25 $0.01 4.21% 122,998 $0.24 $0.25 $0.24
    22 Nov 2024 $0.24 $0.00 0.00% 167,398 $0.24 $0.24 $0.24

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    31 Oct 2024 Clayton Astles Issued 821,739 $209,543
    Issue of securities. 1,499,225 Rights
    21 Oct 2024 Clayton Astles Sell 428,746 $103,417
    On-market trade.
    25 Sep 2024 James Brett Burns Buy 104,166 $24,999
    On-market trade.
    12 Sep 2024 Clayton Astles Exercise 1,350,000 $175,500
    Exercise of options.
    12 Sep 2024 Clayton Astles Buy 1,350,000 $175,500
    Exercise of options.
    30 May 2024 Clayton Astles Sell 400,000 $74,945
    On-market trade.
    23 May 2024 Anthony Glenning Issued 46,037 $8,516
    Rights issue.
    23 May 2024 James Brett Burns Issued 6,880 $1,272
    Rights issue.
    23 May 2024 Graeme Billings Issued 23,078 $4,269
    Rights issue.
    23 May 2024 James Brett Burns Issued 48,857 $9,038
    Rights issue.
    07 Feb 2024 Clayton Astles Exercise 241,661 $31,415
    Exercise of options.
    07 Feb 2024 Clayton Astles Buy 241,661 $31,415
    Exercise of options.
    29 Dec 2023 Clayton Astles Exercise 884,615 $114,999
    Exercise of options. As per announcement on 05-01-2024
    29 Dec 2023 Clayton Astles Buy 884,615 $114,999
    Exercise of options.
    29 Dec 2023 Clayton Astles Transfer 504,823 $100,964
    Off-market transfer. As per announcement on 05-01-2024, assuming off market transfer of shares
    29 Dec 2023 Clayton Astles Transfer 504,823 $100,964
    Off-market transfer. assuming off market transfer of shares
    29 Dec 2023 Clayton Astles Sell 793,796 $151,511
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr James Brett Francis Burns Non-Executive Director Oct 2015
    Mr Burns is Managing Partner of boutique corporate law firm CBW Partners specializing in mergers, acquisitions, debt and equity capital markets and governance for ASX Listed companies. During Brett's more than 25-year career he has served as Company Secretary and General Counsel for an ASX listed Top 20 Company, in private practice with national and international law firms and in regulatory roles with the Australian Securities and Investments Commission.
    Mr Graeme Ambery Billings Non-Executive ChairmanNon-Executive Director Oct 2015
    Mr Billings retired from PriceWaterhouseCoopers in 2011 after 34 years. He is a former head of the Melbourne assurance practice as well as heading the firm's Australian and global industrial products business. He has had experience providing assurance, transaction, and consulting services to multinational and national companies across a variety of industries. Mr Billings is Chairman of the Company's Risk Management Committee.
    Mr Clayton Astles Chief Executive OfficerExecutive Director Aug 2015
    Mr Astles has over 20 years leadership experience in the healthcare technology industry.
    Mr Anthony James Glenning Non-Executive Director Sep 2018
    Mr Glenning has had a career spanning 25 years in the software development industry, 14 of those years living and working in Silicon Valley. In 1999, he founded Tonic Systems, a web application development company which he built up over 8 years and sold to Google in 2007 as part of the Google doc suite of products. He transferred to Google post-acquisition where he worked as Senior Software Engineer for two years.
    Ms Ann Larkins Non-Executive Director Dec 2024
    Ms Ann Larkins worked as the Executive Director and Chief Information Officer (CIO) at the
    Australian Red Cross Lifeblood, Before her role at Lifeblood, Ann held senior leadership positions at Barwon Health and Alfred Health, where she led innovative projects as Executive Director and CIO across Health Information Services and ICT Divisions.
    Mr Brendan Maher Chief Operating Officer- ANZChief Financial OfficerCompany Secretary Oct 2018
    -
    Brendan Maher Chief Operating Officer- ANZChief Financial OfficerCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    National Nominees Limited 63,930,720 17.72%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 52,412,871 14.53%
    Asia Pac Holdings Pty Ltd 19,488,748 5.40%
    Asia Pac Technology Pty Ltd 18,681,085 5.18%
    HSBC Custody Nominees (Australia) Limited 14,234,856 3.95%
    Moat Investments Pty Ltd <Moat Investment A/C> 10,131,219 2.81%
    Dixson Trust Pty Ltd 9,504,433 2.63%
    Asia Pac Holdings Pty Ltd <Asia Pac Holdings A/C> 8,948,764 2.48%
    Mast Financial Pty Ltd <A To Z Investment A/C> 7,515,965 2.08%
    Hestfield Pty Ltd <Neil Eaton Family A/C> 5,029,914 1.39%
    Gliocas Investments Pty Ltd <Gliocas Growth Fund A/C> 4,612,803 1.28%
    Sean Elias Family Investments Pty Ltd <Sean Elias Family Inv A/C> 4,348,773 1.21%
    Bill Brooks Pty Ltd <Bill Brooks Super Fund A/C> 4,305,738 1.19%
    Mrs Emma Jane Gracey 4,151,987 1.15%
    Mr Sean Patrick Martin <The Avebury Family A/C> 4,128,484 1.14%
    Asia Pac Technology Pty Ltd <John Bennetts S/F A/C> 4,083,245 1.13%
    Rokatel Pty Ltd 3,888,889 1.08%
    LZ New Century Pty Ltd 3,700,000 1.03%
    Asia Pac Holdings Pty Ltd i 3,502,738 0.97%
    Mr Erich Gustav Brosell 3,343,403 0.93%

    Profile

    since

    Note